{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T12:48:12Z","timestamp":1784033292330,"version":"3.55.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T00:00:00Z","timestamp":1649116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T00:00:00Z","timestamp":1649116800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"NIH-funded CCASAnet","award":["U01AI069923"],"award-info":[{"award-number":["U01AI069923"]}]},{"name":"NIH-funded CCASAnet","award":["K24 AI065298"],"award-info":[{"award-number":["K24 AI065298"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Some tuberculosis (TB) treatment guidelines recommend daily TB treatment in both the intensive and continuation phases of treatment in HIV-positive persons to decrease the risk of relapse and acquired drug resistance. However, guidelines vary across countries, and treatment is given 7, 5, 3, or 2\u00a0days\/week. The effect of TB treatment intermittency in the continuation phase on mortality in HIV-positive persons on antiretroviral therapy (ART), is not well-described.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We conducted an observational cohort study among HIV-positive adults treated for TB between 2000 and 2018 and after enrollment into the Caribbean, Central, and South America network for HIV epidemiology (CCASAnet; Brazil, Chile, Haiti, Honduras, Mexico and Peru). All received standard TB therapy (2-month initiation phase of daily isoniazid, rifampin or rifabutin, pyrazinamide\u2009\u00b1\u2009ethambutol) and continuation phase of isoniazid and rifampin or rifabutin, administered concomitantly with ART. Known timing of ART and TB treatment were also inclusion criteria. Kaplan\u2013Meier and Cox proportional hazards methods compared time to death between groups. Missing model covariates were imputed via multiple imputation.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>2303 patients met inclusion criteria: 2003(87%) received TB treatment 5\u20137\u00a0days\/week and 300(13%) 2\u20133\u00a0days\/week in the continuation phase. Intermittency varied by site: 100% of patients from Brazil and Haiti received continuation phase treatment 5\u20137\u00a0days\/week, followed by Honduras (91%), Peru (42%), Mexico (7%), and Chile (0%). The crude risk of death was lower among those receiving treatment 5\u20137 vs. 2\u20133\u00a0days\/week (HR\u2009=\u20090.68; 95% CI\u2009=\u20090.51\u20140.91; P\u2009=\u20090.008). After adjusting for age, sex, CD4, ART use at TB diagnosis, site of TB disease (pulmonary vs. extrapulmonary), and year of TB diagnosis, mortality risk was lower, but not significantly, among those treated 5\u20137\u00a0days\/week vs. 2\u20133\u00a0days\/week (HR 0.75, 95%CI 0.55\u20131.01; P\u2009=\u20090.06). After also stratifying by study site, there was no longer a protective effect (HR 1.42, 95%CI 0.83\u20132.45; P\u2009=\u20090.20).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>TB treatment 5\u20137\u00a0days\/week was associated with a marginally decreased risk of death compared to TB treatment 2\u20133\u00a0days\/week in the continuation phase in multivariable, unstratified analyses. However, little variation in TB treatment intermittency within country meant the results could have been driven by other differences between study sites. Therefore, randomized trials are needed, especially in heterogenous regions such as Latin America.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12879-022-07330-5","type":"journal-article","created":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T14:33:49Z","timestamp":1649169229000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Tuberculosis treatment intermittency in the continuation phase and mortality in HIV-positive persons receiving antiretroviral therapy"],"prefix":"10.1186","volume":"22","author":[{"given":"Brenda","family":"Crabtree-Ramirez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cathy A.","family":"Jenkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan E.","family":"Shepherd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karu","family":"Jayathilake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valdilea G.","family":"Veloso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Carriquiry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Gotuzzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia P.","family":"Cortes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis","family":"Padgett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"McGowan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Sierra-Madero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena","family":"Koenig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean W.","family":"Pape","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy R.","family":"Sterling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the CCASAnet Region of IeDEA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Cahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carina","family":"Cesar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Fink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zulma","family":"Ortiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florencia","family":"Cahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agustina","family":"Roldan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ines","family":"Aristegui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Frola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Grinsztejn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valdilea G.","family":"Veloso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula M.","family":"Luz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra Cardoso","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Friedman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronaldo I.","family":"Moreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lara Esteves","family":"Coelho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica Derrico","family":"Pedrosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guilherme Amaral","family":"Calvet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugo","family":"Perazzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo","family":"Moreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Pia Diniz","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario Sergio","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilia Moreira","family":"Jalil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Pinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavia","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelle","family":"Maia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aida","family":"de F\u00e1tima Barbosa Gouv\u00eaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiana","family":"do Carmo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Cortes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo","family":"Wolff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Fernanda","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Castillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gladys","family":"Allendes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean William","family":"Pape","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa Rouzier Adias","family":"Marcelin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youry","family":"Macius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephano Saint","family":"Preux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena","family":"Koenig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco Tulio Luque Diana","family":"Varela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magda","family":"Chavez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ada","family":"Mailhot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis","family":"Padgett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Sierra","family":"Madero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brenda Crabtree","family":"Ramirez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanink Caro","family":"Vega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Gotuzzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Mejia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Carriquiry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"CMcGowan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephany N.","family":"Duda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan E.","family":"Shepherd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Sterling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna K","family":"Person","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter F.","family":"Rebeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Castilho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William C.","family":"Wester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"Clouse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karu","family":"Jayathilake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernanda Maruri Hilary","family":"Vansell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina Cruvinel","family":"Figueiredo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cathy","family":"Jenkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahra Kim Sarah","family":"Lotspeich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paridhi","family":"Ranadive","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"Clouse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,5]]},"reference":[{"issue":"8","key":"7330_CR1","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1093\/cid\/cis630","volume":"55","author":"F Ahmad","year":"2012","unstructured":"Ahmad F, Minion J, Al-Motairi A, Benedetti A, Harries AD, Menzies D. An updated systematic review and meta-analysis on the treatment of active tuberculosis in patients with HIV infection. Clin Infect Dis. 2012;55(8):1154\u201363.","journal-title":"Clin Infect Dis"},{"issue":"10","key":"7330_CR2","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1164\/rccm.200605-637OC","volume":"174","author":"KC Chang","year":"2006","unstructured":"Chang KC, Leung CC, Yew WW, Chan SL, Tam CM. Dosing schedules of 6-month regimens and relapse for pulmonary tuberculosis. Am J Respir Crit Care Med. 2006;174(10):1153\u20138.","journal-title":"Am J Respir Crit Care Med"},{"key":"7330_CR3","doi-asserted-by":"publisher","first-page":"87s","DOI":"10.1183\/09031936.02.00309102","volume":"36","author":"MD Iseman","year":"2002","unstructured":"Iseman MD. Tuberculosis therapy: past, present and future. Eur Respir J Suppl. 2002;36:87s\u201394s.","journal-title":"Eur Respir J Suppl"},{"key":"7330_CR4","doi-asserted-by":"publisher","unstructured":"Cohn DL, Catlin BJ, Peterson KL, Judson FN, Sbarbaro JA. Ann Intern Med. 1990;112(6):407\u201315. doi https:\/\/doi.org\/10.7326\/0003-4819-76-3-112-6-407","DOI":"10.7326\/0003-4819-76-3-112-6-407"},{"key":"7330_CR5","unstructured":"World Health Organization WH, Global Tuberculosis Programme. WHO treatment guidelines for drug-resistant tuberculosis\u202f: 2016 update. Who. 2016:56."},{"key":"7330_CR6","unstructured":"Guidelines for intensified tuberculosis case-finding and isoniazid preventive therapy for people living with HIV in resource-constrained settings. Department of HIV\/AIDS. Stop TB Department. World Health Organization. 2008."},{"issue":"7","key":"7330_CR7","doi-asserted-by":"publisher","first-page":"e147","DOI":"10.1093\/cid\/ciw376","volume":"63","author":"P Nahid","year":"2016","unstructured":"Nahid P, Dorman SE, Alipanah N, Barry PM, Brozek JL, Cattamanchi A, et al. Official American Thoracic Society\/Centers for Disease Control and Prevention\/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis. Clin Infect Dis. 2016;63(7):e147\u201395.","journal-title":"Clin Infect Dis"},{"key":"7330_CR8","unstructured":"Salud M De. Atenci\u00f3n Integral De Las Personas Afectadas Por Tuberculosis 2013;1:172."},{"key":"7330_CR9","unstructured":"Gu\u00eda de Pr\u00e1ctica Cl\u00ednica, Diagn\u00f3stico y Tratamiento de Casos Nuevos de Tuberculosis Pulmonar. M\u00e9xico: Secretar\u00eda de Salud; 2009."},{"issue":"8","key":"7330_CR10","first-page":"51","volume":"21","author":"JC Bossio","year":"2009","unstructured":"Bossio JC, Moral M, Arias S, Barrera L, Imaz S. Enfermedades Infecciosas, Tuberculosis. Guia para el Equipo de Salud. Enfermedades Infecc. 2009;21(8):51.","journal-title":"Enfermedades Infecc."},{"key":"7330_CR11","unstructured":"Minist\u00e9rio da sa\u00fade. Recomenda\u00e7\u00f5es para o manejo da coinfec\u00e7\u00e3o TB-HIV em servi\u00e7os de aten\u00e7\u00e3o especializada a pessoas vivendo com HIV\/AIDS. Secretaria Executiva-Brasilia: Minist\u00e9rio da sa\u00fade 2013;1\u201330."},{"key":"7330_CR12","first-page":"7","volume":"1","author":"BB Guide","year":"2017","unstructured":"Guide BB, Gibson BT. Guia B\u00e1sico para preven\u00e7\u00e3o, diagn\u00f3stico e tratamento da tuberculose em pessoas vivendo com HIV. Programa Estadual DST\/AIDS SP. 2017;1:7\u201319.","journal-title":"Programa Estadual DST\/AIDS SP"},{"key":"7330_CR13","unstructured":"Ministere de la Sante Publique et de la Population. Manuel de normes du programme national de lutte contre la tuberculosse; Direction de la Pr\u00e9vention; 2010."},{"key":"7330_CR14","first-page":"1","volume":"143","author":"Ministerio de Salud","year":"2018","unstructured":"de Salud Ministerio, del Per\u00fa Rep\u00fablica. Norma T\u00e9cnica de Salud para la Prevenci\u00f3n y Control de la coinfecci\u00f3n Tuberculosis y Virus de la Inmunodeficiencia Humana en el Per\u00fa. Ministerio de Salud MINSA\/DGIESP. 2018;143:1.","journal-title":"Ministerio de Salud MINSA\/DGIESP."},{"issue":"9","key":"7330_CR15","doi-asserted-by":"publisher","first-page":"e1000150","DOI":"10.1371\/journal.pmed.1000150","volume":"6","author":"D Menzies","year":"2009","unstructured":"Menzies D, Benedetti A, Paydar A, Royce S, Madhukar P, Burman W, et al. Standardized treatment of active tuberculosis in patients with previous treatment and\/or with mono-resistance to isoniazid: a systematic review and meta-analysis. PLoS Med. 2009;6(9):e1000150.","journal-title":"PLoS Med."},{"issue":"9","key":"7330_CR16","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1093\/cid\/cix121","volume":"64","author":"JC Johnston","year":"2017","unstructured":"Johnston JC, Campbell JR, Menzies D. Effect of intermittency on treatment outcomes in pulmonary tuberculosis: an updated systematic review and metaanalysis. Clin Infect Dis. 2017;64(9):1211\u201320.","journal-title":"Clin Infect Dis"},{"issue":"3\u20134","key":"7330_CR17","doi-asserted-by":"publisher","first-page":"117","DOI":"10.3121\/cmr.2015.1272","volume":"13","author":"S Kasozi","year":"2015","unstructured":"Kasozi S, Clark J, Doi SA. Intermittent versus daily pulmonary tuberculosis treatment regimens: a meta-analysis. Clin Med Res. 2015;13(3\u20134):117\u201338.","journal-title":"Clin Med Res."},{"issue":"17","key":"7330_CR18","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1056\/NEJMoa1407426","volume":"371","author":"SH Gillespie","year":"2014","unstructured":"Gillespie SH, Crook AM, McHugh TD, Mendel CM, Meredith SK, Murray SR, et al. REMoxTB Consortium. Four-month moxifloxacin-based regimens for drug-sensitive tuberculosis. N Engl J Med. 2014;371(17):1577\u201387.","journal-title":"N Engl J Med."},{"issue":"6","key":"7330_CR19","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1164\/rccm.200904-0536OC","volume":"180","author":"JL Johnson","year":"2009","unstructured":"Johnson JL, Hadad DJ, Dietze R, Maciel EL, Sewali B, Gitta P, et al. Shortening treatment in adults with noncavitary tuberculosis and 2-month culture conversion. Am J Respir Crit Care Med. 2009;180(6):558\u201363.","journal-title":"Am J Respir Crit Care Med"},{"issue":"14","key":"7330_CR20","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1001\/jama.2011.436","volume":"305","author":"C Lienhardt","year":"2011","unstructured":"Lienhardt C, Cook SV, Burgos M, Yorke-Edwards V, Rigouts L, Anyo G, et al. Trial Group. Efficacy and safety of a 4-drug fixed-dose combination regimen compared with separate drugs for treatment of pulmonary tuberculosis: the Study C randomized controlled trial. JAMA. 2011;305(14):1415\u201323.","journal-title":"JAMA."},{"issue":"17","key":"7330_CR21","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1056\/NEJMoa1315817","volume":"371","author":"CS Merle","year":"2014","unstructured":"Merle CS, Fielding K, Sow OB, Gninafon M, Lo MB, Mthiyane T, et al. OFLOTUB\/Gatifloxacin for Tuberculosis Project A four-month gatifloxacin-containing regimen for treating tuberculosis. N Engl J Med. 2014;371(17):1588\u201398.","journal-title":"N Engl J Med."},{"issue":"4","key":"7330_CR22","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1001\/jamainternmed.2018.0141","volume":"178","author":"N Gopalan","year":"2018","unstructured":"Gopalan N, Santhanakrishnan RK, Palaniappan AN, Menon PA, Lakshman S, Chandrasekaran P, et al. Daily vs. intermittent antituberculosis therapy for pulmonary tuberculosis in patients with HIV: a randomized clinical trial. JAMA Intern Med. 2018;178(4):485\u201393.","journal-title":"JAMA Intern Med"},{"issue":"13","key":"7330_CR23","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1186\/1471-2334-13-468","volume":"7","author":"R Vashishtha","year":"2013","unstructured":"Vashishtha R, Mohan K, Singh B, Devarapu SK, Sreenivas V, et al. Efficacy and safety of thrice weekly DOTS in tuberculosis patients with and without HIV co-infection: an observational study. BMC Infect Dis. 2013;7(13):468.","journal-title":"BMC Infect Dis"},{"key":"7330_CR24","doi-asserted-by":"publisher","first-page":"937817","DOI":"10.1155\/2014\/937817","volume":"2014","author":"G Alvarez-Uria","year":"2014","unstructured":"Alvarez-Uria G, Midde M, Pakam R, Naik PK. Directly-observed intermittent therapy versus unsupervised daily regimen during the intensive phase of antituberculosis therapy in HIV infected patients. Biomed Res Int. 2014;2014:937817.","journal-title":"Biomed Res Int."},{"key":"7330_CR25","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1089\/aid.2014.0241","volume":"31","author":"MJ Giganti","year":"2015","unstructured":"Giganti MJ, Luz PM, Caro-Vega Y, Cesar C, Padgett D, Koenig S, Echevarria J, McGowan CC, Shepherd BE. A comparison of seven Cox regression-based models to account for heterogeneity across multiple HIV treatment cohorts in Latin America and the Caribbean. AIDS Res Hum Retroviruses. 2015;31:496\u2013503.","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"1","key":"7330_CR26","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1093\/cid\/ciz1032","volume":"71","author":"SP Koenig","year":"2020","unstructured":"Koenig SP, Kim A, Shepherd BE, et al. Increased mortality after tuberculosis treatment completion in persons living with human immunodeficiency virus in Latin America. Clin Infect Dis. 2020;71(1):215\u20137. https:\/\/doi.org\/10.1093\/cid\/ciz1032.","journal-title":"Clin Infect Dis"},{"issue":"9","key":"7330_CR27","doi-asserted-by":"publisher","first-page":"e74057","DOI":"10.1371\/journal.pone.0074057","volume":"8","author":"CP Cortes","year":"2013","unstructured":"Cortes CP, Wehbe FH, McGowan CC, Shepherd BE, Duda SN, Jenkins CA, et al. Caribbean, Central American, South American Network for HIV Research of the International Epidemiologic Databases to Evaluate AIDS. Duration of anti-tuberculosis therapy and timing of antiretroviral therapy initiation: association with mortality in HIV-related tuberculosis. PLoS One. 2013;8(9):e74057.","journal-title":"PLoS One."},{"issue":"5","key":"7330_CR28","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1093\/ije\/dym073","volume":"36","author":"CC McGowan","year":"2007","unstructured":"McGowan CC, Cahn P, Gotuzzo E, Padgett D, Pape JW, Wolff M, Schechter M. Cohort Profile: Caribbean, Central and South America Network for HIV research (CCASAnet) collaboration within the International Epidemiologic Databases to Evaluate AIDS (IeDEA) programme. Int J Epidemiol. 2007;36(5):969\u201376.","journal-title":"Int J Epidemiol"},{"issue":"9","key":"7330_CR29","doi-asserted-by":"publisher","first-page":"e44793","DOI":"10.1371\/journal.pone.0044793","volume":"7","author":"RA Murphy","year":"2012","unstructured":"Murphy RA, Marconi VC, Gandhi RT, Kuritzkes DR, Sunpath H. Coadministration of lopinavir\/ritonavir and rifampicin in HIV and tuberculosis co-infected adults in South Africa. PLoS ONE. 2012;7(9):e44793.","journal-title":"PLoS ONE."},{"issue":"8","key":"7330_CR30","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.3851\/IMP1455","volume":"14","author":"G Maartens","year":"2009","unstructured":"Maartens G, Decloedt E, Cohen K. Effectiveness and safety of antiretrovirals with rifampicin: crucial issues for high-burden countries. Antivir Ther. 2009;14(8):1039\u201343.","journal-title":"Antivir Ther"},{"key":"7330_CR31","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1186\/s12879-018-3077-x","volume":"18","author":"Y Caro-Vega","year":"2018","unstructured":"Caro-Vega Y, Schultze A, Efsen AM, et al. Differences in response to antiretroviral therapy in HIV-positive patients being treated for tuberculosis in Eastern Europe, Western Europe and Latin America. BMC Infectious Diseases. 2018;18:191. https:\/\/doi.org\/10.1186\/s12879-018-3077-x.","journal-title":"BMC Infectious Diseases"},{"issue":"6","key":"7330_CR32","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1093\/ije\/dyv295","volume":"45","author":"LE Cain","year":"2016","unstructured":"Cain LE, Saag MS, Petersen M, May MT, Ingle SM, Logan R, et al. Antiretroviral Therapy Cohort Collaboration, the Centers for AIDS Research Network of Integrated Clinical Systems, and the HIV-CAUSAL Collaboration. Using observational data to emulate a randomized trial of dynamic treatment-switching strategies: an application to antiretroviral therapy. Int J Epidemiol. 2016;45(6):2038\u201349.","journal-title":"Int J Epidemiol."},{"issue":"9","key":"7330_CR33","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.5588\/ijtld.15.0997","volume":"20","author":"JD Jenks","year":"2016","unstructured":"Jenks JD, Kumarasamy N, Ezhilarasi C, Poongulali S, Ambrose P, Yepthomi T, et al. Improved tuberculosis outcomes with daily vs. intermittent rifabutin in HIV-TB coinfected patients in India. Int J Tuberc Lung Dis. 2016;20(9):1181\u20134.","journal-title":"Int J Tuberc Lung Dis."}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-022-07330-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-022-07330-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-022-07330-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T14:34:12Z","timestamp":1649169252000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-022-07330-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,5]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["7330"],"URL":"https:\/\/doi.org\/10.1186\/s12879-022-07330-5","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,5]]},"assertion":[{"value":"21 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Institutional review board approval was obtained locally for each participating site for the constitution of the CCASAnet cohort, and data are coordinated by the Vanderbilt University Medical Center, Nashville, TN, USA. At each of the sites contributing data for this study, except the participant site in Peru (Instituto de Medicina Tropical Alexander von Humboldt, IMTAvH); the Ethic Committee of Instituto Nacional de Infectologia Evandro Chagas, in Brazil; the Ethic Committee of Fundaci\u00f3n Arriar\u00e1n, in Chile; the Ethic Committee of Le Groupe Ha\u00eftien d'Etude du Sarcome de Kaposi et des Infections Opportunistes (GHESKIO), in Haiti; the Ethic Commitee of Hospital Escuela and Instituto Hondure\u00f1o de Seguridad Social, in Honduras; and the Ethic Committee of Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubir\u00e1n, in Mexico permit retrospective analysis of de-identified clinical data without informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"341"}}